SAN FRANCISCO, Sept. 5, 2019 /PRNewswire/ -- Glaucoma Research Foundation (GRF), a national non-profit organization dedicated to finding a cure for glaucoma, announced results from a national survey designed to assess the impact of glaucoma on patients and caregivers, as well as to identify their information and support needs. Survey findings reveal t

NEW YORK, Sept. 5, 2019 /PRNewswire/ -- To coincide with Suicide Prevention Awareness Month (September), the Ad Council's Seize the Awkward campaign is launching a new video series starring musicians

MADISON, N.J., Sept. 5, 2019 /PRNewswire/ -- Sotheby's International Realty Affiliates LLC today announced that Sage Realty Partners in

SOUTHBOROUGH, Mass., Sept. 5, 2019 /PRNewswire/ -- NeurAegis, Inc., a privately held pharmaceutical company pioneering the development of breakthrough treatments for neurological disorders, announced today that its scientific founder, Dr. Michel Baudry, has been awarded a multi-year, $3.8 million grant fro

HEDERA, Israel, Sept. 5, 2019 /PRNewswire/ -- Polytex Technologies is pleased to announce it has received a major investment by private equity fund Fortissimo Capital, and welcomes its newly appointed CEO, Yariv Matzliach.Fortissimo, a leading Israeli private equity fund that invests primarily in technology and ind

TEL AVIV, Israel, Sept. 5, 2019 /PRNewswire/ -- iCAN Connect, New York's first-ever Israeli Cannabis Investor Symposium will take place on Thursday, September 12, 2019 at the Green Fig Restaurant, 570 10th Ave., providing investors the opportunity to learn about the highly innovative Israeli cannabis industry, meet executives and resea

SAN DIEGO, Sept. 5, 2019 /PRNewswire/ -- Medical Marijuana, Inc. ("the Company") (OTC: MJNA), the first-ever publicly traded cannabis company in

NEW YORK, Sept. 5, 2019 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) announced today the awarding of 25 new MDA grants totaling more than $6.6 million toward research focused on a variety of neuromuscular diseases (NMDs), including amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease (CMT), congenital muscular dystrophy (CMD), Duchenne m

ABBOTT PARK, Ill., Sept. 5, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the launch of the company's TRILUMINATE Pivotal trial to evaluate the safety and effectiveness of the company's TriClip transcatheter tricuspid valve repair system for the treatment of severe tricuspid regurgitation (TR). This is the first pivotal Investigational Device Exemption (IDE) trial in the U.S. to evaluate

PALO ALTO, Calif. and WASHINGTON, Sept. 5, 2019 /PRNewswire/ -- Martis Capital announced that it has closed a minority recapitalization with Credible Behavioral Health, Inc. ("Credible"), a leading provider of electronic health record and practice management Software-as-a-Service solutions to the U.S. behavioral healthcare market. Through